BB2121-EAP-001: Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release
- Title
- Expanded Access Protocol (EAP) for Subjects Receiving Idecabtagene Vicleucel That is Nonconforming for Commercial Release
- Principal Investigator
- Veltri, Lauren
- Phase
- NA
- Age Group
- Adult
- Applicable Disease Sites
- Multiple Myeloma
- Participating Institutions
- Mary Babb Randolph Cancer Center
- Contacts
- Crystal Peck, RN
- BMT Coordinator
- Phone: +1 304-598-4500
- Email: peckc@wvumedicine.org